Free subscription to the Capitol Journal keeps you current on legislative and regulatory news.
CA to Cap Health Care Providers’ Annual Price Increases at 3% California’s Health Care Affordability Board voted to limit annual price increases from doctors, hospitals and health insurers...
VT Retailers Fight Data Privacy Bill Orvis and other online retailers based in Vermont are mounting an effort to scale back comprehensive consumer data privacy legislation ( HB 121 ) that has been passed...
Even as states are falling behind on their greenhouse gas emissions goals , that topic remains a top priority in legislatures across the country. Numerous bills have been introduced this year that would...
States Loosening Occupational Licensing Laws In an effort to boost their workforces, states are advancing legislation to loosen their occupational licensing laws. For example, the Louisiana House passed...
ME House Passes Restrictive Data Privacy Bill Maine’s House narrowly approved a bill ( LD 1977 ) that would impose restrictions on the digital information that companies can collect. Businesses...
Federal officials have uncovered significant problems with the systems and procedures states have been employing to “unwind” Medicaid coverage protections put in place during the pandemic. A senior official at the Centers for Medicare and Medicaid Services said many states have been conducting automatic or “ex parte” renewals based on state databases to determine whether residents are still eligible for Medicaid coverage, sending out renewal forms and disenrolling anyone who doesn’t return them. (NEW YORK TIMES)
The Centers for Medicare and Medicaid Services announced the first 10 medications selected for price negotiations with Medicare in accordance with the Inflation Reduction Act, signed by President Biden in August 2022. CMS prioritized drugs that account for the most Medicare spending and came on the market years ago but face little competition. (NEW YORK TIMES)
A group of 11 governors, led by South Dakota Gov. Kristi Noem (R), sent a letter to congressional leaders urging them to take action to address shortages of prescription drugs. Noting that 80% of the active ingredients in prescription drugs come from other countries, mainly China and India, the governors called for policies to "increase diversity in the manufacturing of generic medications with regards to both raw materials and final manufacturing," require greater transparency from the FDA regarding shortages and relax the guidance for medication expiration dates to extend its shelf life. (CENTER SQUARE)
—Compiled by SNCJ Managing Editor KOREY CLARK
Please visit our webpage to connect with a State Net® representative and learn how the State Net legislative and regulatory tracking solution can help you identify, track, analyze and report on relevant legislative and regulatory developments.